A

SEC EDGAR - Form 4 insider activity

Akari Therapeutics PLC $AKTX

Tracked equity - 7 filings indexed by Nortis

Nortis signal thesis

Cluster activity detected. Review whether the filings are open-market trades or routine compensation events.

0

OM buys - 90d

0

OM sells - 90d

7

Routine filings

6

Cluster filings

$136.2K

Largest trade

14/100

Avg signal score

Filing tape

Recent filings

Last 30d: 7
Grant / AwardCLUSTERRoutine 15/100
filed 2026-10-16
PRBoard

Prudo-Chlebosz Raymond - Director - $71.7K

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Grant / AwardCLUSTERRoutine 15/100
filed 2026-10-16
HHBoard

Huh Hoyoung - Director, 10% Owner - $136.2K

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Grant / AwardCLUSTERRoutine 15/100
filed 2026-10-16
PIBoard

Patel Sandip I - Director - $95.6K

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Grant / AwardCLUSTERRoutine 15/100
filed 2026-10-16
BBBoard

Bazemore Robert B - Director - $103.5K

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Option ExerciseCLUSTERRoutine 15/100
filed 2026-10-16
GACEO

Gaslightwala Abizer - Director, CEO - $7.73

Option exercises are often compensation mechanics rather than a direct market view; what happens to the shares next matters more. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Grant / AwardCLUSTERRoutine 15/100
filed 2026-10-16
PRBoard

Patel Samir Rashmikant - Director - $49.8K

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Grant / AwardRoutine 10/100
filed 2026-10-01
GACEO

Gaslightwala Abizer - Director, CEO - $62.5K

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy.

View source filing